GlycoNex Incorporation (4168.TWO)
TWD 17.05
(3.65%)
TWD 17.05
(3.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -126.82 Million TWD | 27.61% |
| 2022 | -175.5 Million TWD | -32.37% |
| 2021 | -132.36 Million TWD | -17.81% |
| 2020 | -113.27 Million TWD | 47.93% |
| 2019 | -193.18 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -63.63 Million TWD | -16.04% |
| 2024 Q2 | -40.05 Million TWD | 37.06% |
| 2023 Q2 | 27.44 Million TWD | 156.85% |
| 2023 Q4 | -54.83 Million TWD | -7.18% |
| 2023 Q3 | -51.16 Million TWD | -286.41% |
| 2023 FY | - TWD | 27.61% |
| 2023 Q1 | -48.27 Million TWD | 24.36% |
| 2022 Q4 | -63.82 Million TWD | 0.0% |
| 2022 FY | - TWD | -32.37% |
| 2021 FY | - TWD | -17.81% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 132.222% |
| Level Biotechnology Inc. | 98.7 Million TWD | 228.492% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -183.482% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -75.868% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 11.739% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -22.402% |
| Visgeneer Inc. | 973 Thousand TWD | 13134.635% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 113.543% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 227.034% |
| Neith Corporation | -33.61 Million TWD | -277.349% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -7201.497% |
| Enimmune corporation | -228.96 Million TWD | 44.608% |
| TaiRx, Inc. | -208.64 Million TWD | 39.214% |
| EirGenix Inc. | -664.4 Million TWD | 80.911% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 271.61% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 283.427% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -58.391% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -12.131% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 464.048% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -382.232% |
| RBC Bioscience Corporation | 36.54 Million TWD | 447.024% |
| BiOptic Inc. | 65.03 Million TWD | 295.004% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -174.256% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -284.254% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -130.951% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 129.253% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 62.641% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 87.203% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -103.441% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -402.624% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 681.508% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -615.486% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 88.163% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 81.416% |
| VBI | -6.97 Million TWD | -1719.091% |
| CHO Pharma, Inc. | -277.73 Million TWD | 54.335% |
| NaviFUS Corp. | -55.79 Million TWD | -127.309% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -664.11% |
| Sinew Pharma Inc. | -163.63 Million TWD | 22.492% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -106.223% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 165.918% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 44.05% |
| AP Biosciences Inc | -325.51 Million TWD | 61.038% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 87.859% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -253.811% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 535.383% |
| Intech Biopharm Corporation | -219.58 Million TWD | 42.242% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 81.189% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -182.145% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 21.155% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 119.347% |
| TCI GENE Inc. | 25.98 Million TWD | 588.153% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -14.632% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 55.309% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 13.114% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 1015.718% |
| PharmaEngine, Inc. | 347.3 Million TWD | 136.517% |
| Savior Lifetec Corporation | 219.6 Million TWD | 157.752% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 173.638% |
| OBI Pharma, Inc. | -855.08 Million TWD | 85.168% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -37.017% |
| Acepodia, Inc. | -764.51 Million TWD | 83.411% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 72.434% |